The 2024 conference has 28 late-breakers plus plenty of basic and population science. More than anything, it’s a celebration.

In high- and standard-risk patients CAS and TCAR look good, but some worry about skill sets, learning curves, and ...

The latest version of the LLM had high concordance with a multidisciplinary heart team in choosing between PCI and CABG.

Ami Bhatt asks Kate Dalton to share details on the challenges of early feasibility studies from her perspective as a clinical site coordinator.

Ami Bhatt and Michael Mack explain the economics of AI use in the detection of subclinical cardiovascular disease.

While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.